Illumina, Inc. (ILMN)
NASDAQ • Healthcare
Last close at November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Illumina, Inc. keeps $19 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Feb 4
in 75 daysQ1 2027% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Illumina’s adjusted EPS topped consensus in the third fiscal quarter of 2026, based on preliminary results reported October 29, 2026, with adjusted EPS of $1.62 topping the $1.36 estimate (+19.1%). Revenue rose 4.2% to about $1.1 billion (up from $1.083 billion a year ago), reflecting results across its sequencing and array offerings, while GAAP gross profit was roughly $830.0 million and profitability ran at a gross margin of ~74% alongside an operating margin of 27.0%. GAAP operating income came in around $305.0 million, and net income increased 46.7% to roughly $220.0 million (up from $150.0 million a year ago), while adjusted EPS was up 20.9% from $1.34 a year ago. The quarter generated operating cash flow of about $419.0 million. For the next period, consensus calls for EPS of $1.50.
About Illumina, Inc.
Illumina, Inc. (NASDAQ: ILMN) develops genetic and genomic analysis tools for the healthcare sector, selling instruments, consumables, services, and cancer detection tests used across research and clinical settings in medical diagnostics and research. In FY2025, the company recorded $4.3 billion in revenue.
Today's Snapshot
ILMN closed 3.9% lower at 192.82, while its sector was flat. Illumina's AI research lab won a competition for CellularAI, its cell-behavior prediction tool.
Trading Volume
Above 10d avg 1.6M
1.9M
vs S&P 500 Today
Moderate Underperformance
-0.41%
Updated: November 20, 2026 at 21:27 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$190.12 - $232.40Sell
- RSI (14)33.59Neutral
- Stochastic %K (14, 3, 3)11.35Buy
- MACD Level (12, 26)-15.65Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.